Common Bile Duct Diseases
10
1
1
2
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
10.0%
1 terminated out of 10 trials
66.7%
-19.8% vs benchmark
10%
1 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (10)
Diclofenac for Prevention of Post-ERC Pancreatitis
Effects of Dexamethasone on Common Bile Duct Cannulation Time
A Prospective Study on the Safety and Efficacy of Robot-assisted Pancreaticoduodenectomy
A Multicenter Prospective Randomized Controlled Study of RPD Versus LPD
A Prospective Clinical Study Using an Artery-first Intermediate Approach in Robot-assisted Pancreaticoduodenectomy
Double Guidewire Technique Versus Transpancreatic Precut in Patients With Repetitive Unintentional Cannulation of the Pancreatic Duct.
Assessment of Cholangio-pancreatoscopy for the Diagnosis and the Treatment of Biliary and Pancreatic Diseases
Digital SpyGlass Confirmed Common Bile Duct Stones Clearance Without Fluoroscopy
Early Precut in Difficult Biliary Cannulation
A Comparison of Bile Duct Injuries Following Open Cholecystectomy Versus Laparoscopic Cholecystectomy